Emery; Stephen Charles

Patent Applications and Registrations

Patent applications and USPTO patent grants for Emery; Stephen Charles.The latest application filed is for "combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer".

Company Profile

0.5.14

Emery; Stephen Charles - Winterley GB
Emery; Stephen Charles - Macclesfield GB
Emery; Stephen Charles - Winterly Cheshire GB
Emery; Stephen Charles - Cheshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies directed to angiopoietin-2 and uses thereof Grant 10,066,011 - Green , et al. September 4, 2	2018-09-04
Combination Of Angiopoietin-2 Antagonist And Of Vegf-a, Kdr And/or Flt1 Antagonist For Treating Cancer App 20160251421 - Brown; Jeffrey Lester ; et al.	2016-09-01
Antibodies Directed To Angiopoietin-2 And Uses Thereof App 20150125455 - GREEN; Larry L. ; et al.	2015-05-07
Antibodies directed to angiopoietin-2 and uses thereof Grant 8,834,880 - Green , et al. September 16, 2	2014-09-16
Combination Of Angiopoietin-2 Antagonist And Of Vegf-a, Kdr And/or Flt1 Antagonist For Treating Cancer App 20140023654 - BROWN; Jeffrey Lester ; et al.	2014-01-23
Antibodies Directed To Angiopoietin-2 And Uses Thereof App 20130171160 - Green; Larry L. ; et al.	2013-07-04
Combination Of Angiopoietin-2 Antagonist And Of Vegf-a, Kdr And/or Flt1 Antagonist For Treating Cancer App 20120288497 - BLAKEY; DAVID CHARLES ; et al.	2012-11-15
Targeted Binding Agents Directed To Upar And Uses Thereof App 20120108797 - Elvin; Paul ; et al.	2012-05-03
Antibodies Directed to Angiopoietin-2 And Uses Thereof App 20120052073 - Green; Larry L. ; et al.	2012-03-01
Targeted binding agents directed to uPAR and uses thereof Grant 8,026,344 - Zhou , et al. September 27, 2	2011-09-27
Antibodies directed to angiopoietin-2 and uses thereof Grant 7,973,140 - Green , et al. July 5, 2	2011-07-05
Combination Of Angiopoietin-2 Antagonist And Of Vegf-a, Kdr And/or Flt1 Antagonist For Treating Cancer App 20110097321 - BLAKEY; David Charles ; et al.	2011-04-28
Targeted Binding Agents Directed To Upar And Uses Thereof App 20090123476 - Elvin; Paul ; et al.	2009-05-14
Combination Of Angiopoietin-2 Antagonist And Of Vegf-a, Kdr And/or Fltl Antagonist For Treating Cancer App 20090123474 - Blakey; David Charles ; et al.	2009-05-14
Antibodies Directed to Angiopoietin-2 and Uses Thereof App 20080267971 - Green; Larry L. ; et al.	2008-10-30
TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF App 20080152587 - Zhou; Qing ; et al.	2008-06-26
Antibodies directed to angiopoietin-2 and uses thereof App 20060246071 - Green; Larry ; et al.	2006-11-02
Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic use Grant 6,903,203 - Copley , et al. June 7, 2	2005-06-07
Monoclonal antibody to CEA, conjugates comprising said antibody, and their therapeutic use in an adept system App 20020142359 - Copley, Clive Graham ; et al.	2002-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.